|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.14 USD | -1.78% |
|
+6.88% | +42.91% |
| Capitalization | 71Cr 61Cr 57Cr 53Cr 98Cr 6.11TCr 109.6Cr 693.08Cr 260.95Cr 2.86TCr 266.51Cr 260.99Cr 11TCr | P/E ratio 2025 * |
-5.44x | P/E ratio 2026 * | -16.1x |
|---|---|---|---|---|---|
| Enterprise value | 70Cr 60Cr 56Cr 52Cr 96Cr 5.98TCr 107.22Cr 678.07Cr 255.3Cr 2.8TCr 260.74Cr 255.34Cr 10TCr | EV / Sales 2025 * |
5.61x | EV / Sales 2026 * | 2.71x |
| Free-Float |
90.82% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: UroGen Pharma Ltd.
More recommendations
More press releases
| 1 day | -1.82% | ||
| 1 week | +6.88% | ||
| Current month | +11.09% | ||
| 1 month | +2.35% | ||
| 3 months | +57.56% | ||
| 6 months | +49.36% | ||
| Current year | +42.91% |
| 1 week | 13.79 |  | 15.8 |
| 1 month | 12.73 | | 15.8 |
| Current year | 3.42 | | 15.8 |
| 1 year | 3.42 | | 17 |
| 3 years | 3.42 | | 24.13 |
| 5 years | 3.42 | | 28.2 |
| 10 years | 3.42 | | 69.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 03/01/2019 | |
Chris Degnan
DFI | Director of Finance/CFO | 45 | 08/10/2024 |
Jason Smith
CMP | Compliance Officer | 53 | 09/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 75 | 01/10/2012 |
Stuart Holden
BRD | Director/Board Member | 83 | 01/12/2015 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 01/10/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.78% | +6.88% | -8.53% | +69.30% | 71Cr | ||
| 0.00% | +2.12% | +15.27% | +34.73% | 3.48TCr | ||
| +2.80% | +15.51% | +106.58% | -22.84% | 3.23TCr | ||
| -0.66% | -1.96% | +28.14% | -31.27% | 2.73TCr | ||
| -0.72% | +9.16% | +179.90% | +2,358.56% | 2.05TCr | ||
| -0.93% | +5.17% | +37.57% | +356.49% | 1.98TCr | ||
| +0.86% | +24.29% | +249.57% | +515.75% | 1.6TCr | ||
| +0.88% | +7.13% | +154.00% | -62.61% | 1.47TCr | ||
| +0.12% | +2.94% | -23.39% | -44.11% | 1.36TCr | ||
| -0.51% | -0.60% | +97.65% | +106.72% | 1.22TCr | ||
| Average | +0.01% | +6.35% | +83.68% | +328.07% | 1.92TCr | |
| Weighted average by Cap. | +0.33% | +5.49% | +84.89% | +329.07% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 12Cr 11Cr 9.97Cr 9.24Cr 17Cr 1.07TCr 19Cr 120.86Cr 46Cr 499.15Cr 46Cr 46Cr 1.84TCr | 26Cr 22Cr 21Cr 19Cr 36Cr 2.23TCr 40Cr 252.53Cr 95Cr 1.04TCr 97Cr 95Cr 3.84TCr |
| Net income | -14Cr -12Cr -11Cr -10Cr -19Cr -1.19TCr -21Cr -134.42Cr -51Cr -555.11Cr -52Cr -51Cr -2.05TCr | -4.22Cr -3.64Cr -3.4Cr -3.15Cr -5.8Cr -363.19Cr -6.51Cr -41Cr -16Cr -170.06Cr -16Cr -16Cr -626.91Cr |
| Net Debt | -1.54Cr -1.33Cr -1.24Cr -1.15Cr -2.11Cr -132.35Cr -2.37Cr -15Cr -5.65Cr -62Cr -5.77Cr -5.65Cr -228.45Cr | -94.68L -81.7L -76.19L -70.6L -1.3Cr -81Cr -1.46Cr -9.24Cr -3.48Cr -38Cr -3.55Cr -3.48Cr -140.61Cr |
More financial data
* Estimated data
Employees
234
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/25/18 | 15.22 $ | -1.23% | 1,59,856 |
| 17/25/17 | 15.41 $ | +7.46% | 20,30,033 |
| 16/25/16 | 14.34 $ | +2.14% | 7,75,921 |
| 15/25/15 | 14.04 $ | -3.11% | 5,84,712 |
| 14/25/14 | 14.49 $ | +1.76% | 11,72,958 |
Delayed Quote Nasdaq, July 18, 2025 at 07:44 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
15.41USD
Average target price
34.38USD
Spread / Average Target
+123.07%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- URGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition